1. Royalty Pharma Appoints Henry A. Fernandez and Ted W. Love, M.D. to the Company’s Board of Directors

    Royalty Pharma Appoints Henry A. Fernandez and Ted W. Love, M.D. to the Company’s Board of Directors

    NEW YORK, Royalty Pharma (Nasdaq: RPRX) today announced the appointments of Henry A. Fernandez and Ted W. Love, M.D. to the company's Board of Directors, effective immediately. Mr. Fernandez is Chairman and Chief Executive Officer of MSCI Inc., a leading global provider of investment decision support tools. Dr. Love is President and Chief Executive Officer of Global Blood Therapeutics, a biopharmaceutical company focused on the treatment and care of sickle cell disease...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. Following our successful initial public offering, we are further strengthening the governance of Royalty Pharma with the appointments to the Board of Henry Fernandez and Ted Love.
    2. Both are highly entrepreneurial and bring exceptional leadership qualities achieved over long and successful careers in finance and the research-based biopharma industry, respectively. Their experience, knowledge and business acumen will be invaluable to the company as we continue our journey as the leading funder of innovation in the biopharma ecosystem.
  3. Topics Mentioned

  4. Authors